"Drugs that would qualify would include those that don’t have generic or what is called biosimilar equivalents — copies of more complex drugs. Depending on their type, it would have to be nine or more years since their approval by the Food and Drug Administration, which means newer drugs would not be included."

Not sure how to think about this. Would this wind up limiting choices?

Part of being in a democracy, especially one split so close to evenly in the government. It’s all about compromise and gamesmanship.